Search

HNM01

It entered Phase 1 clinical trials for the treatment of HIV infections but was discontinued during this phase

Lucanthone

One of the schistosomicides, it has been replaced largely by hycanthone and more recently praziquantel. (From Martindale The Extrapharmacopoeia, 30th ed., p46). It is currently being tested as a radiation sensitizer.

Acebutolol

A cardioselective beta-adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm as well as weak inherent sympathomimetic action.

ACY001

ST-36

In 2017, it received orphan drug designation by the FDA for the treatment of glioma.[L47341]

Phelimin

[L48151] It is under investigation for the treatment of hyperphenylalaninemia.

NKG2D-ACE2 CAR-NK Cell

The GM-CSF acts as a neutralizer for the CAR-T cell-mediated cytokine release and neurotoxicity. … The transmembrane NKG2D and intracellular 2B4 domains are required for optimal NK signalling and subsequent cell-mediated cytotoxicity.

Vicriviroc

Vicriviroc, also known as SCH 417690 and SCH-D, is currently in clinical trials for the management of HIV-1.

Carumonam

Brodimoprim